We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
-13.73%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$129M
AUM Growth
-$37.6M
(-23%)
Cap. Flow
-$4.56M
Cap. Flow
% of AUM
-3.54%
Top 10 Holdings %
Top 10 Hldgs %
35.03%
Holding
142
New
9
Increased
21
Reduced
68
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VLRX
VALERITAS HOLDINGS INC
VLRX
|
+$1.22M |
| 2 |
AVGR
Avinger, Inc. Common Stock
AVGR
|
+$970K |
| 3 |
Ciena
CIEN
|
+$959K |
| 4 |
Microvision
MVIS
|
+$931K |
| 5 |
OptimizeRx
OPRX
|
+$879K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPS Commerce
SPSC
|
+$2.08M |
| 2 |
VRAY
ViewRay, Inc.
VRAY
|
+$1.2M |
| 3 |
BioLife Solutions
BLFS
|
+$1.06M |
| 4 |
CRZO
Carrizo Oil & Gas Inc
CRZO
|
+$929K |
| 5 |
Deluxe
DLX
|
+$814K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 65.66% |
| 2 | Technology | 13.8% |
| 3 | Industrials | 5.1% |
| 4 | Communication Services | 4.86% |
| 5 | Consumer Discretionary | 3.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Vericel Corp
VCEL
$2.1B
| $9.48M | 7.35% |
545,050
-4,700
| -0.9% | -$70.3K |
|
2
Axogen
AXGN
$2.77B
| $7.28M | 5.64% |
356,175
-2,825
| -0.8% | -$88.4K |
|
3
Abbott
ABT
$195B
| $5.56M | 4.31% |
76,900
-150
| -0.2% | -$10.5K |
|
4
CareDx
CDNA
$2.58B
| $4.98M | 3.86% |
197,960
-13,100
| -6% | -$337K |
|
5
NeoGenomics
NEO
$2.32B
| $3.55M | 2.75% |
281,500
-2,400
| -0.8% | -$35.8K |
|
6
Apyx Medical
APYX
$130M
| $3.02M | 2.34% |
465,700
+350
| +0.1% | +$2.12K |
|
7
Pfizer
PFE
$159B
| $2.93M | 2.27% |
70,654
-564
| -0.8% | -$23.4K |
|
8
Sensus Healthcare
SRTS
$57.9M
| $2.85M | 2.21% |
384,836
-12,000
| -3% | -$76.2K |
|
9
Standard BioTools
LAB
$252M
| $2.8M | 2.17% |
324,800
+106,300
| +49% | +$828K |
|
10
Eli Lilly
LLY
$1.05T
| $2.73M | 2.12% |
23,610
| – | – |
|
11
Veracyte
VCYT
$3.48B
| $2.63M | 2.04% |
208,705
-2,850
| -1% | -$33.7K |
|
12
Idexx Laboratories
IDXX
$43.7B
| $2.48M | 1.93% |
13,350
| – | – |
|
13
Magnite
MGNI
$3.4B
| $2.41M | 1.87% |
646,750
-33,750
| -5% | -$129K |
|
|
CSII
14
DELISTED
Cardiovascular Systems, Inc.
CSII
| $2.4M | 1.86% |
84,150
+14,900
| +22% | +$473K |
|
|
15
OptimizeRx
OPRX
$150M
| $2.36M | 1.83% |
214,896
+59,446
| +38% | +$879K |
|
16
AtriCure
ATRC
$2.47B
| $2.32M | 1.8% |
75,750
-500
| -0.7% | -$15.6K |
|
17
Microsoft
MSFT
$3.81T
| $2.11M | 1.64% |
20,810
| – | – |
|
|
TEUM
18
DELISTED
Pareteum Corporation
TEUM
| $1.64M | 1.27% |
968,979
-39,750
| -4% | -$82.5K |
|
19
CryoPort
CYRX
$815M
| $1.63M | 1.26% |
147,900
-8,500
| -5% | -$92.4K |
|
20
Aflac
AFL
$58.4B
| $1.59M | 1.23% |
34,850
| – | – |
|
|
TTSH
21
DELISTED
Tile Shop Holdings
TTSH
| $1.56M | 1.21% |
285,600
-10,000
| -3% | -$61.2K |
|
22
Tactile Systems Technology
TCMD
$525M
| $1.56M | 1.21% |
34,305
-200
| -0.6% | -$11.5K |
|
23
LeMaitre Vascular
LMAT
$1.84B
| $1.52M | 1.18% |
64,400
| – | – |
|
24
ANI Pharmaceuticals
ANIP
$1.67B
| $1.47M | 1.14% |
32,700
-250
| -0.8% | -$13.1K |
|
|
CYBE
25
DELISTED
Cyberoptics Corp
CYBE
| $1.44M | 1.12% |
81,750
-12,500
| -13% | -$237K |
|
Similar funds
AA
WA
AC
BCVI
SWM
HAP
RHIG
CWM
Perkins Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, Perkins Capital Management held 142 positions worth $129M, down 23% from $167M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Perkins Capital Management withdrew a net $4.56M in Q4 2018, closing 15 positions and reducing 68 holdings. Its most notable exit was SPS Commerce, an estimated $2.08M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 66% of assets, up from 64% a quarter earlier, followed by Technology and Industrials.
Against the trend, Perkins Capital Management opened a new position in VALERITAS HOLDINGS INC worth $493K.
- Perkins Capital Management's largest Q4 2018 buy was VALERITAS HOLDINGS INC: 75,750 shares worth $493K.
- Perkins Capital Management added most to Microvision in Q4 2018, an estimated $931K increase.
- Perkins Capital Management's biggest Q4 2018 reduction was ViewRay, Inc., cutting an estimated $1.2M.
- Perkins Capital Management fully exited SPS Commerce in Q4 2018, selling an estimated $2.08M.
- Perkins Capital Management's ten largest holdings make up 35% of its $129M portfolio in Q4 2018.
- Perkins Capital Management opened 9 new positions and closed 15 in Q4 2018.
- Perkins Capital Management's portfolio value fell 23% quarter-over-quarter to $129M.
Based on Perkins Capital Management's 13F filing for Q4 2018, filed 11 Feb 2019.